Skip to main navigation Skip to search Skip to main content

Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy

*Corresponding author for this work
  • Sheba Medical Center at Tel Hashomer
  • National Institutes of Health
  • University of Pennsylvania
  • Complete Healthcare Communications, Inc.
  • University of Exeter
  • Department of Pediatrics
  • Inova Health System
  • Children's National Medical Center
  • Tel Aviv University

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Abstract

Cellular distribution and dynamics of mitochondria are regulated by several motor proteins and a microtubule network. In neurons, mitochondrial trafficking is crucial because of high energy needs and calcium ion buffering along axons to synapses during neurotransmission. The trafficking kinesin proteins (TRAKs) are well characterized for their role in lysosomal and mitochondrial trafficking in cells, especially neurons. Using whole exome sequencing, we identified homozygous truncating variants in TRAK1 (NM_001042646:c.287-2A 4 C), in six lethal encephalopathic patients from three unrelated families. The pathogenic variant results in aberrant splicing and significantly reduced gene expression at the RNA and protein levels. In comparison with normal cells, TRAK1-deficient fibroblasts showed irregular mitochondrial distribution, altered mitochondrial motility, reduced mitochondrial membrane potential, and diminished mitochondrial respiration. This study confirms the role of TRAK1 in mitochondrial dynamics and constitutes the first report of this gene in association with a severe neurodevelopmental disorder.

Original languageEnglish
Pages (from-to)568-581
Number of pages14
JournalBrain
Volume140
Issue number3
DOIs
StatePublished - 1 Mar 2017

Funding

FundersFunder number
Israeli Centers of Excellence
NGHRI
Kahn Family Foundation
Wellcome Trust316723, WT105618MA, WT097835MF
Israeli Centers for Research Excellence
UK Research and Innovation
NIH Office of the DirectorR01OD010944
Office of Naval ResearchN000141410538
Israel Science Foundation41/11
Biotechnology and Biological Sciences Research CouncilBB/K006231/1
National Human Genome Research InstituteZIDHG200352, ZIAHG000215

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Early-onset epilepsy
    • Mitochondria transport
    • Neurodegeneration
    • Rare diseases
    • TRAK1

    Fingerprint

    Dive into the research topics of 'Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy'. Together they form a unique fingerprint.

    Cite this